Alexandra Lucas

Founding Scientist Serpass Biologics

Seminars

Wednesday 9th December 2026
Virus-derived Immune Modulating Serpin Biologic Targets Complement to Inhibit Inflammation
2:30 pm
  • Viruses have evolved highly potent immune modulators
  • Treatment with a Myxomavirus derived serpin, PEGylated Serp-1, reduces inflammation and coagulation disorders in multiple animal models
  • PEGSerp-1 regulates multiple complement proteases
Alexandra Lucas Founding Scientist Serpass Biologics - Expert Speaker at the 10th Complement-Based Drug Development Summit